Page 55 - textbook5chapters
P. 55
Technique of Intraperitoneal Chemotherapy: Normothermic and Hyperthermic 1307
54. Passot G, Bakrin N, Isaac S, et al. Postoperative outcomes 59. Chua TC, Yan TD, Saxena A, et al. Should the treatment
of laparoscopic vs open cytoreductive surgery plus of peritoneal carcinomatosis by cytoreductive surgery
hyperthermic intraperitoneal chemotherapy for treatment and hyperthermic intraperitoneal chemotherapy still
of peritoneal surface malignancies. Eur J Surg Oncol 2014; be regarded as a highly morbid procedure? A systematic
40 (8):957-962. review of morbidity and mortality. Ann Surg 2009; 249
(6):900-907
55. Esquivel J, Averbach A, Chua TC. Laparoscopic
cytoreductive surgery and hyperthermic intraperitoneal 60. Chan DL, Morris DL, Rao A, et al. Intraperitoneal
chemotherapy in patients with limited peritoneal surface chemotherapy in ovarian cancer: a review of tolerance and
malignancies: feasibility, morbidity and outcome in an efficacy. Cancer Manag Res 2012:4: 413–422
early experience. Ann Surg. 2011;253(4):764-768
61. Furet E, Chereau E, Lambaudie E, Bannier M, Houvenaeghel
56. Ferron G, Gesson-Paute A, Classe JM, et al. Feasibility of G. Feasibility, morbidity and survival of surgery combined
laparoscopic peritonectomy followed by intra-peritoneal with HIPEC in the management of recurrent ovarian
chemohyperthermia: an experimental study. Gynecologic cancer. Gynecol Obstet Fertil 2013; 41:493-498.
Oncology 2005; 99: 358-361.
62. Halkia E, Kopanakis N, Nikolaou G, et al. Cytoreductive
57. Helm CW, Richard SD, Pan J, et al. Hyperthermic surgery and HIPEC for peritoneal carcinomatosis. A
intraperitoneal chemotherapy in ovarian cancer: first review on morbidity and mortality. J BUON 2015; 20:S80-
report of the HYPER-O registry. Int J Gynecol Cancer 7.
2010; 20:61-69.
63. Cascales Campos P, Gil J, Parrilla P. Morbidity and mortality
58. Chua TC, Robertson G, Liauw W, et al. Intraoperative outcomes of cytoreductive surgery and hyperthermic
hyperthermic intraperitoneal chemotherapy after intraperitoneal chemotherapy in patients with primary
cytoreductive surgery in ovarian cancer peritoneal and recurrent advanced ovarian cancer. Eur J Surg Oncol
carcinomatosis: systematic review of current results. J 2014; 40: 970-75
Cancer Res Clin Oncol 2009;135:1637-1645
